Artificial Intelligence, Drug Pricing, Mergers

Key Takeaways from the 2025 JP Morgan Healthcare Conference

Morgan Lewis - As Prescribed on 2/3/2025

Several members of our firm’s life sciences team were on the ground at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco from January 13 to 16, 2025. It was an exciting and sunny four days, during which key...more

2025 Top-of-Mind Issues for Life Sciences Companies

Sheppard Mullin Richter & Hampton LLP on 1/31/2025

DTC Telehealth Platforms - Arrangements involving telemedicine and direct-to-consumer (“DTC”) business services are expected to be a source of major regulatory scrutiny. In 2024, such arrangements were the focus of proposed...more

Life Sciences Year in Review and What's Ahead

DLA Piper on 1/8/2025

2024 was eventful in the life sciences space – and key trends are expected to continue in the new year. ...more

2024 Top-of-Mind Issues for Life Sciences Companies

Sheppard Mullin Richter & Hampton LLP on 1/26/2024

As we reflect on 2023 and make predictions for 2024, it is remarkable the number of significant events occurring this past year that will be impactful for the activities of the life sciences industry going forward. Although...more

Healthcare Authority Newsletter - July 2023 #2

Arnall Golden Gregory LLP on 7/20/2023

News Briefs - States Investigate Nonprofit Hospitals' Lack of Charity Care - More than a dozen states have considered or passed legislation to better define charity care, to increase transparency about the benefits hospitals...more

Life Sciences and Health Care Horizons - 2018

Hogan Lovells on 4/4/2018

Innovation in the life sciences and health care industries is occurring at a dizzying pace. Five years ago, anti-PD-1 antibodies from Merck and BMS had yet to be approved, CAR-T therapies were still in small-scale clinical...more